Improving Bereavement Outcomes in Zimbabwe: Results of a Feasibility Cluster Trial of the 9-Cell Bereavement Tool
Abstract ContextDespite high mortality rates from both communicable and non-communicable diseases, bereavement studies are under-researched in African countries. The 9-cell bereavement tool was designed to assist individuals to reflect on their feelings in bereavement, and identify resources in families and communities to manage bereavement. This study aimed to determine the feasibility of implementing the 9-cell bereavement tool and recruitment to experimental evaluation. Methods: A feasibility cluster randomized trial with embedded qualitative interviews was conducted in two comparable neighborhoods in Chitungwiza, Zimbabwe. Community leaders identified potential community lay bereavement supporters (interventionists). Each recruited 2-3 recently bereaved community members (trial participants). Following baseline data collection, the communities were randomly allocated to intervention or wait-list control. Self-administered questionnaires were completed at T0 (month 0), T1(3 months) and T2 (6 months). Grief, mental health and social support were assessed. Focus group discussions with selected interventionists described training impact and intervention processes. Quantitative and qualitative analysis were performed. ResultsObjectives were achieved as follows(i) feasibility of recruitment and retention (ii) feasibility of implementing the intervention (iii) determining contamination(iv) completeness of data(v) participants’ views on intervention and mechanisms(vi) estimating potential effect size (vii) determining whether full trial warranted. In line with the aim of the study, the processes of the randomized cluster trial were possible. We successfully conducted the randomized control trial of the 9-cell bereavement tool and successfully recruited study participants. In addition, the 9-cell intervention allowed interventionists to share and learn from their grieving process. All of the above was conducted within the intended timeframe of 3 weeks, with an over recruitment of 112% of interventionists and 43% more trial participants. This means we were able to recruit at least 75% of the suggested sample size; and to retain at least 75% of the trial participants for the total duration of the study. Conclusion The processes of the randomized controlled trial were possible. The 9-cell bereavement intervention was delivered and process data assessed. The study was funded through the BuildCARE fund from the Cicely Saunders Institute of Palliative Care, Policy and Rehabilitation Protocol Registration: http://www.isrctn.com/ISRCTN16484746.Protocol Publication: https://pilotfeasibilitystudies.biomedcentral.com/articles/10.1186/s40814-019-0450-5